China Pharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 04:06 pm EST
China Pharma Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 1.8 million compared to USD 1.97 million a year ago. Net loss was USD 0.7776 million compared to USD 0.790773 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.8 a year ago. Diluted loss per share from continuing operations was USD 0.3 compared to USD 0.8 a year ago.
For the nine months, sales was USD 4.86 million compared to USD 5.18 million a year ago. Net loss was USD 1.85 million compared to USD 2.71 million a year ago. Basic loss per share from continuing operations was USD 0.9 compared to USD 2.8 a year ago. Diluted loss per share from continuing operations was USD 0.9 compared to USD 2.8 a year ago.